Global expansion Illingworth operates in more than 46 countries with a focus on home health clinical research services, patient concierge, and site support, presenting opportunities to cross-sell expanded CRO services to global biopharma and medical device clients seeking international trial delivery.

Patient-centric services With in-house patient concierge and ground/air transportation plus accommodation and reimbursement capabilities, there is a strong upsell case to sponsors needing patient access optimization and higher retention in decentralized or centralized trials.

Syneos Health backing As a Syneos Health company with Queen’s Award and ongoing global presence, there is credibility to approach enterprise sponsors seeking integrated CRO and clinical research home health solutions, enabling bundled service proposals.

Managed scalability PMaaS and flexible staffing (ramping teams up or down) align with sponsors’ fluctuating trial demand, enabling faster project starts, reduce idle resources, and position Illingworth as a partner for adaptive trial execution.

Leadership & growth Recent leadership appointments and sustained growth in US and international markets signal a scalable operations platform and potential for strategic collaborations, especially with mid-to-large biopharma seeking enhanced patient care and regulatory-compliant site support.